Forget Aurora Cannabis (TSX:ACB) and Consider This Pot Stock for Massive Gains

While Aurora Cannabis stock continues to burn investor wealth, this pot company is poised to beat market returns in 2020.

| More on:
Cannabis stocks have fallen.
You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

We have seen how Aurora Cannabis (TSX:ACB)(NYSE:ACB) stock has been decimated over the last year. Shares are trading 84% below 52-week highs and investors are patiently waiting for a turnaround.

But Aurora Cannabis is grappling with several issues. Its high debt balance of $796 million is a major concern. Comparatively, the company has a cash balance of $192 million and operating cash flows of -$218 million. This indicates Aurora Cannabis can run out of cash if it does not improve profit margins at a fast pace.

Another issue is the competition from illegal sales that still accounts for 40% of total cannabis sales in Canada. The slower than expected rollout of retail stores in major Canadian provinces has also led to high inventory levels, further pressurizing sales and the bottom line.

Last week, Aurora Cannabis announced the exit of its founder and CEO. It also announced a 15% cut in the workforce and the company also released preliminary quarterly results that were below consensus estimates, resulting in a 16% drop in stock price on Friday.

And it’s not just Aurora Cannabis: several other pot stocks have lost billions of dollars in market value in the last 12-months. However, the pot industry is still in a nascent stage, which means it will grow at a rapid pace over the years.

So how do investors take advantage of this growth? Well, there is one pot company that is relatively safe and even provides a dividend. Yes, you heard that right.

Innovative Industrial Properties Inc.

Innovative Industrial Properties Inc. (NYSE:IIPR) is not your traditional pot company. It does not have greenhouse facilities to manufacture products. IIPR focuses on the acquisition, ownership and management of industrial properties, which it leases to licensed cannabis producers.

IIPR acquires properties through sale-leaseback transactions and third-party purchases. This business model has served the company well. In the September quarter, IIPR more than tripled rental sales year over year, while adjusted funds from operations more than quadrupled.

The company owns 49 properties in 15 states south of the border. Some of its clients are large cannabis companies such as Cresco Labs and Trulieve Cannabis.

IIPR has increased sales from USD $0.32 million in 2016 to USD $14.8 million in 2018. Analysts expect sales to reach USD $166 million by the end of 2021.

IIPR shares went public in December 2016 and closed trading at USD $18.45 on December 2 of that year. The stock has gained 400% in just over three years. While most pot stocks have lost over 60% in market value in the last year, IIPR is trading 34% below its 52-week high.

Another encouraging aspect of the stock is the company’s forward dividend yield of 4.3%. Although IIPR has a debt balance of $134 million, with cash reserves of $100 million and operating cash flows of $31.2 million, it can easily service debt obligations.

IIPR has a capital intensive business model, which means that it will have to issue additional capital to sustain its aggressive expansion goals.

However, the company is already profitable, with a forward price-to-earnings multiple of 20.5 — an absolute bargain given that earnings could rise 134.7% in 2019 and 156.2% in 2020.

Analysts covering IIPR have an average 12-month price target of USD $140.5, which is 52% above the current trading price.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »